Dare Bioscience (DARE) Assets Average (2014 - 2026)
Dare Bioscience's (DARE) quarterly Assets Average came in at $31.6 million in Q4 2025, up 57.43% YoY from $20.1 million in Q4 2024, and up 44.58% on a QoQ basis from $21.9 million in Q3 2025.
Dare Bioscience (DARE) Assets Average (2014 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 12 years of Assets Average data on file, last reported at $31.6 million in Q4 2025.
- Quarterly Assets Average rose 57.43% year-over-year to $31.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $31.6 million (up 57.43% YoY) and the FY2025 annual result came in at $27.3 million, up 25.8% from the prior year.
- Assets Average improved to $31.6 million in Q4 2025, from $21.9 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $52.5 million in Q1 2022 to a low of $9.0 million in Q1 2021.
- A 5-year average of $29.2 million and a median of $23.7 million in 2023 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2021 — Assets Average soared 587.72% — and 2024, when it sank 53.78%.
- Tracing DARE's Assets Average over 5 years: stood at $52.3 million in 2021, then declined by 9.96% to $47.1 million in 2022, then plunged by 50.81% to $23.2 million in 2023, then declined by 13.33% to $20.1 million in 2024, then jumped by 57.43% to $31.6 million in 2025.
- The last three Assets Average figures came in at $31.6 million (Q4 2025), $21.9 million (Q3 2025), and $15.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Dare Bioscience | 11.91 Mn | -705,728.22 | -132,343.00 | 27.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.42 Mn |
| Dec 31, 2025 | 31.61 Mn |
| Sep 30, 2025 | 21.86 Mn |
| Jun 30, 2025 | 15.80 Mn |
| Mar 31, 2025 | 20.36 Mn |
| Dec 31, 2024 | 20.08 Mn |
| Sep 30, 2024 | 20.83 Mn |
| Jun 30, 2024 | 18.31 Mn |
| Mar 31, 2024 | 17.15 Mn |
| Dec 31, 2023 | 23.17 Mn |
| Sep 30, 2023 | 24.13 Mn |
| Jun 30, 2023 | 26.79 Mn |
| Mar 31, 2023 | 37.10 Mn |
| Dec 31, 2022 | 47.10 Mn |
| Sep 30, 2022 | 50.89 Mn |
| Jun 30, 2022 | 50.29 Mn |
| Mar 31, 2022 | 52.50 Mn |
| Dec 31, 2021 | 52.31 Mn |
| Sep 30, 2021 | 31.82 Mn |
| Jun 30, 2021 | 12.67 Mn |